Recent in vivo models demonstrated that immune checkpoint cancer therapy can be improved by injecting interleukine (IL)-18, a proinflammatory cytokine of the IL-1 family. Aiming to increase the beneficial action of cytokines in cancer treatments, we used docking, non-covalent interaction analysis and molecular dynamics simulations to determine their ability for embedding alkaloid-based drugs. Our calculations suggest that three alkaloids with anticancer activity, e.g., paclitaxel, vincristine and vinorelbine, can be used to efficiently stabilize the crystal-tetrameric form of IL-18 while being retained in their core region. The reported results pave a new synthetic route for designing bifunctional host-guest systems with an enhanced biological activity.
Introduction
The use of plant-derived extracts as anticancer agents has attracted an increasing attention with a particular focus on alkaloids, which are known to exhort a strong activity against tumors [1] . Indeed, alkaloid-based drugs have been proposed for the treatment of several disorders, including carcinomas as well as lung, prostate and breast cancers [2] . The biological mechanism of alkaloids is rather complex at the cellular level, but the inhibition of the microtubulin function is now accepted to be the key step in their anticancer activity [3] . Unfortunately, this reaction is not site specific and alkaloids show severe side effects due to their high cytotoxicity in healthy cells [4] .
To circumvent chemotherapy risks, novel drugs can be encapsulated into a carrier molecule [5] , namely the formation of a host-guest complex that avoids an early activation of the embedded drug while concentrating their action in the malignant tissues [6] . Within this framework, Yadav an co-workers have recently used theoretical simulations to determine the ability of trastuzumab (Herceptin ® ) to embed the alkaloids shown in Fig. 1 : paclitaxel (Taxol ® ), vincristine (Oncovin ® ) and vinorelbine (Navelbine ® ) [7] . Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2/neu over-expressed protein in breast cancer patients [8, 9] . In this case, both carrier and cargo molecules posses anticancer activity, so that they can be defined as bifunctional drugs [10] [11] [12] [13] [14] .
Inspired by those previously findings, herein we used computational simulations to assess the application of interleukin (IL)-18 as carrier molecule of these three alkaloids. IL-18 is a proinflammatory cytokine of the IL-1 family that improves immune checkpoint blocking cancer therapy [15] . Although its biological mechanism of action is still under debate, the beneficial effects of IL-18 might be associated with the activation of cytotoxic pre-mNK cells, low accumulation of regulatory T cells, and suppression of soluble inhibitor secretion of IL-10 and TGF [15] . The crystal structure of IL-18 was recently resolved by Tsutsumi and co-workers as a tetramer [16] . That self-assembled form matches previous experimental results in solution, where an equilibrium between monomeric and tetrameric units was detected [17, 18] .
The present contribution provides the first comprehensive insights into the use of IL-18 cytokine as carrier material for paclitaxel, vincristine and vinorelbine anticancer drugs. More specifically, blind docking (BD), molecular dynamics (MD) simulations and non-covalent interaction (NCI) analyses are carried out to assess the distribution of potential binding sites across the surface of the IL-18 protein in its tetrameric form, and the stability of the embedded alkaloids. The performed simulations demonstrated that IL-18 may be self-assembled in the presence of a third party molecule, which in turn may be used as a carrier molecule for a selective delivery. The reported theoretical predictions can help to improve immune checkpoint cancer immunotherapy based on novel IL-18 bifunctional carrier-cargo systems.
Computational details
The initial model for the host system was built up from the crystal structure recently resolved by Tsutsumi and co-workers, which was deposited at the Protein Data Bank (PDB) [19] with code 1WO2 [16] . Hydrogen atoms were added, and cap termini were included with the Protein Preparation Wizard module implemented in Maestro [20] . Protonation states of all side chains were defined at pH = 7 using PROPKA 3.1 [21] . The three selected alkaloids (paclitaxel, vincristine and vinorelbine) were subsequently docked into the refined IL-18 structure by using a BD approach [22] . For the records, the same pH conditions are used to determine the protonation states of these three alkaloids (see Fig. 1 ). Multiple parallel and independent docking simulations were performed around geometric centers of all residues. BD scheme provides a first glimpse on the ligand interaction pattern with IL-18, namely, which residues of the protein are involved (not restricted to a particular cavity, but considering the whole protein surface), and how these interactions contribute to the total protein-ligand interaction energy [23] . All individual docking calculations in the BD approach were carried out with AutoDock Vina [24] . The implemented scoring function in AutoDock Vina is composed by two electrostatic terms (specified as gauss1 and gauss2), repulsive, hydrophobic, hydrogen bonds (H-bonds) and an entropic term linearly dependent on the number of rotatable bonds of the ligand. The top BD pose of each alkaloid-based drug, namely the one with the highest value of the scoring function, can be identified as the most favorable binding site.
Although BD provides a cost-effective analysis of the non-covalent interactions present in the binding sites, a more refined scheme is necessary to identify the nature of the chemical interactions established between the drug and the carrier molecule. Consequently, the best poses were retained for the additional analysis with NCIPlot [25, 26] . This code provides a qualitative description of the main chemical contacts present in a host-guest system by combining the electron density over all atoms and the associated gradient ∇ as follows:
This approach enables to visualize weak interactions as colored isosurfaces of the reduced density gradient, s [27] .
To ensure the stability of the formed host-guest adducts, the resulting IL-18-embedded drug model systems were eventually located in an orthorhombic water box by defining a buffer distance of 10 Å in X, Y and Z directions by using the simple point charge (SPC) model [28] . Sodium cations were added to counterbalance the total electric charge ( −19|e| for the embedded paclitaxel system and −17|e| for the vincristine and vinorelbine models). Additional sodium
and chloride ions were added to reproduce the physiological NaCl salt concentration of 0.15 M. The whole solvated host-guest models were initially minimized for 2000 steps with the steepest descent scheme by imposing a convergence threshold of 1.0 kcal/mol/Å. The designed systems were next relaxed with a multi-step protocol that includes a solute-restrained minimization, restrain-free minimization, NVT simulation of 24 ps at T = 10 K, NPT simulations at T = 10 K and P = 1 atm, which is the default protocol implemented in Desmond [29] . For the production phase, the temperature was set to 300 K with the Nosé-Hoover algorithm with a relaxation time of 1.0 ps [30, 31] . Pressure was set at 1 bar using the Martyna-Tobias-Klein barostat with an isotropic coupling and a relaxation time of 2.0 ps [32] . The RESPA integrator was used to integrate equations of motion with a 2.0 fs time step for bonded and close interactions and a 6.0 fs time step for farther interactions [33] . A cutoff of 9 Å was imposed to all non-bonded interactions. Van der Waals interactions were assessed using a cutoff radius of 9 Å, and the electrostatic part was defined using the particle mesh Ewald (PME) method [34] . All MD simulations were carried out for 25 ns by using the OPLS-2005 force field as implemented in Desmond [29] .
Results and discussion
The three selected alkaloids were first docked into IL-18 by exploring the whole protein surface. Results obtained from BD simulations are summarized in Figs. 2 and 3 , which provide information about the location and energetics of the different clusters of poses. As illustrated in Fig. 2 , the three selected alkaloids fit into the central region of the self-assembled IL-18 tautomeric structure. The origin of that alkaloid-binding preference is dependent on the binding contribution of the electrostatic contacts, repulsive forces, hydrophobic interactions, H-bonds and entropic terms. All these contributions are plotted in right panel of Fig. 3 while the histograms of pose clusters are given in the left panel. For the latter, pink bars represent the number of poses whose scoring function value falls into the assigned interval, and blue bars are related to the number of top poses obtained from their corresponding clusters. The top pose from each cluster is the one with the highest scoring function value and a cluster is defined so that it includes overlapping poses. As can be seen, the computed top poses lie to the left end of the histogram with scoring function values larger (more negative) than − 7 kcal/mol. These values indicate a large affinity of the alkaloids for IL-18. The main stabilizing interactions in all cases are related to H-bonds and favorable hydrophobic contacts. These theoretical outcomes therefore hint that alkaloids may act as nucleation site, which in turn shift the equilibrium toward the self-assembled IL-18 tetramer.
As discussed, docking provides a fast evaluation of the protein domain(s) in interaction with drugs, a prerequisite for assessing all possible binding pockets [35] . It is remarkable, however, that the best docking poses include measurable repulsion forces (plotted as red bars in the right panel of Fig. 3 ). Hence, a NCI analysis is performed to increase the accuracy of the drug binding modes, and therefore to determine the residues that exhibit attractive or repulsive interactions with the alkaloid drug. According to the NCI analysis reported in the top panel of Fig. 4 , large attractive interactions are established between these drugs and IL-18. Green surfaces stand for dispersion interactions on the aromatic rings, which partially contribute to fix alkaloids into the binding site. More striking are the observed H-bonds patterns, which are highlighted by blue surfaces in Fig. 4 . Let us start with the pose of paclitaxel resulting form docking, which is located at the top-left panel. Among other contacts, we observe a dispersion attraction with the lateral chain of residue Ile139B. Additional weak contacts appear also with Lys79B and Ile80D. However, these two residues also establish strong H-bonds with paclitaxel, which correspond to the circled-blue surfaces. A close inspection of that region reveals that these contacts are concomitant with red areas, that is, with repulsive contributions due to the spatial proximity of both residues to the alkaloid. Middle panel of Fig. 4 provides further detail into the interactions between vincristine and IL-18. In this case, the ligand is anchored through H-bonds with Tyr123B and Leu138B residues, which in turn results in a large value of the scoring function. NCI analysis also allows us to identify the origin of the repulsive attraction, which arises from a clash with the Asn78B residue in the docked structure. Finally, NCI analysis shows a significant amount of weak interactions along the benzenic core of the vinorelbine alkaloid that is complemented with two H-bonds though Tyr123B and Lys140A residues. In that case, a clash with Tyr120A is identified (intense red region).
Until now, all our discussion has been based on the structures arising from docking simulations. However, docking might produce repulsive steric interactions because the conformation of the protein is not adapted to the embedded alkaloid. Following the proposed methodology, MD simulations have been next performed to account for both drug and protein flexibility. Accordingly, the three top BD poses (Fig. 2) are equilibrated in water boxes and subjected to MD simulations during trajectories of 25 ns. Figure 5 shows allheavy atoms root-mean-square displacement (RMSD) of the host relative to its initial structure vs. time for selected alkaloids. All tested systems quickly reach a stable structure, with a constant RMSD variation of ca. 1 Å after 15 ns. MD simulations consequently lead to a similar conclusion: The three selected alkaloid-based anticancer drugs remain within the central region of IL-18, which hints that the formed noncovalent interaction pattern is strong enough to stabilize the cargo inside the host structure. Finally, the NCI analysis is repeated by extracting the binding sites from the last snapshot of the MD trajectory (bottom panel of Fig. 4) . It is worth noting that all clashes disappear during the trajectory. The encapsulation is dominated by weak interactions and strong H-bonds with the Lys140B and Arg27D for paclitaxel, Glu128B for vincristine and Glu121A for vinorelbine.
All accumulated findings confirm that in spite of the limitations associated with BD protocols, docking is a costeffective tool for screening larger libraries, and consequently may be used in the search of other possible drugs that can be encapsulated into the IL-18 structure. However, MD refinement is a key step in the computational protocol to properly [36, 37] . The ability of the NCI analysis to monitor the structure of the binding sites produced by docking and MD calculations allows to delineate the residues that contribute to the encapsulations phenomena. Finally, since the generated tetramer-alkaloid systems are fairly stable in the MD trajectory, we conclude that tetrameric form of IL-18 may act as an efficient carrier for any of these alkaloids.
Conclusions and outlook
Herein, we performed docking, non-covalent analysis and molecular dynamics simulations to assess the possible use of IL-18 as carrier molecule for alkaloid-based anticancer drugs. The major drawback of docking protocols is the lack of protein flexibility, which is kept as a rigid entity upon drug binding. As result, that initial screening may lead to unreliable protein-drug contacts. Indeed, the reported results demonstrated that scoring function might overestimate H-bond contributions, which eventually direct docking to strong attractive interactions that are concomitant with repulsive contacts due to steric clashes. NCI analysis is shown to be an efficient tool to determine the nature of the histograms derived from docking simulations and consequently to help to decide whether a further molecular dynamics refinement is required. The proposed computational protocol suggests that selfassembled tetrameric IL-18 efficiently embeds three alkaloids with anticancer activity, e.g., paclitaxel, vincristine and vinorelbine, in its central region. Of course, a larger panel of anticancer drugs will be required to define the most efficient anticancer drug that can be loaded into the structure of IL-18 cytokine. Simultaneously to the performance of such theoretical calculations, the use of that cytokine as carrier molecule can be already tested in vivo to validate their novel clinical applications.
